IL93477A - Parganadian) or Trian (discussion of acetals and carcasses, their preparation and pharmaceutical preparations containing them - Google Patents

Parganadian) or Trian (discussion of acetals and carcasses, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL93477A
IL93477A IL9347790A IL9347790A IL93477A IL 93477 A IL93477 A IL 93477A IL 9347790 A IL9347790 A IL 9347790A IL 9347790 A IL9347790 A IL 9347790A IL 93477 A IL93477 A IL 93477A
Authority
IL
Israel
Prior art keywords
hydrogen
cyclic
general formula
group
acetal
Prior art date
Application number
IL9347790A
Other languages
English (en)
Hebrew (he)
Other versions
IL93477A0 (en
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IL93477A0 publication Critical patent/IL93477A0/xx
Publication of IL93477A publication Critical patent/IL93477A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL9347790A 1989-03-09 1990-02-21 Parganadian) or Trian (discussion of acetals and carcasses, their preparation and pharmaceutical preparations containing them IL93477A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU891155A HU203769B (en) 1989-03-09 1989-03-09 Process for producing new steroide derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
IL93477A0 IL93477A0 (en) 1990-11-29
IL93477A true IL93477A (en) 1994-07-31

Family

ID=10953084

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9347790A IL93477A (en) 1989-03-09 1990-02-21 Parganadian) or Trian (discussion of acetals and carcasses, their preparation and pharmaceutical preparations containing them

Country Status (19)

Country Link
US (1) US5053404A (sv)
EP (1) EP0387090A3 (sv)
JP (1) JPH075629B2 (sv)
KR (1) KR930009446B1 (sv)
CN (1) CN1045397A (sv)
AR (1) AR245452A1 (sv)
AU (1) AU617929B2 (sv)
BG (1) BG60440B2 (sv)
CA (1) CA2011280A1 (sv)
EG (1) EG19166A (sv)
FI (1) FI901200A0 (sv)
HU (1) HU203769B (sv)
IL (1) IL93477A (sv)
IN (1) IN169862B (sv)
NO (1) NO177099C (sv)
PH (1) PH26685A (sv)
PT (1) PT93374A (sv)
TW (1) TW208020B (sv)
ZA (1) ZA901753B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
FR2675146A1 (fr) * 1991-04-10 1992-10-16 Roussel Uclaf Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
CN110078785A (zh) * 2019-06-04 2019-08-02 博诺康源(北京)药业科技有限公司 一种布地奈德杂质ep-ze的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3167545A (en) * 1959-02-07 1965-01-26 Syntex Corp 16beta-methyl-16alpha, 17 alpha-dihydroxy pregnenes and the 16alpha, 17alpha-cyclic ketals and acetals thereof
US3345362A (en) * 1961-07-27 1967-10-03 Lilly Co Eli Novel pregnenolone acetonides
US3798216A (en) * 1969-03-07 1974-03-19 Fabrication Des Antibiotique S 9-fluoro-11beta,21-dihydroxy-16alpha,17-(2-propenylidenedioxy)-pregna-1,4-diene-3,20-dione and derivatives thereof
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
SE378109B (sv) * 1972-05-19 1975-08-18 Bofors Ab
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
DE3133631A1 (de) * 1981-08-21 1983-03-03 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue kortikoide ihre herstellung und verwendung
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
SE8506015D0 (sv) * 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives

Also Published As

Publication number Publication date
IN169862B (sv) 1992-01-04
ZA901753B (en) 1990-12-28
KR930009446B1 (ko) 1993-10-04
PH26685A (en) 1992-09-15
NO901102D0 (no) 1990-03-08
KR900014423A (ko) 1990-10-23
FI901200A0 (fi) 1990-03-09
AR245452A1 (es) 1994-01-31
BG60440B2 (bg) 1995-03-31
NO177099B (no) 1995-04-10
NO177099C (no) 1995-07-19
CN1045397A (zh) 1990-09-19
HU203769B (en) 1991-09-30
AU5079890A (en) 1990-09-20
EP0387090A3 (en) 1992-05-06
TW208020B (sv) 1993-06-21
CA2011280A1 (en) 1990-09-09
US5053404A (en) 1991-10-01
PT93374A (pt) 1990-11-07
AU617929B2 (en) 1991-12-05
EG19166A (en) 1994-11-30
JPH075629B2 (ja) 1995-01-25
JPH02279697A (ja) 1990-11-15
EP0387090A2 (en) 1990-09-12
NO901102L (no) 1990-09-10
IL93477A0 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
US5482934A (en) Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions
EP0054010B1 (en) 4-pregnene-derivatives, a process for their preparation and composition for the treatment of inflammatory conditions
US4925933A (en) Method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
US5053404A (en) Novel steroid derivatives, pharmaceutical compositions containing them and process for preparing same
US4181720A (en) Corticosteroid antiinflammatory agents
US5082835A (en) Novel steroid diols, pharmaceutical compositions containing them and process for preparing same
EP0200692B1 (en) Androstane-17-beta-carboxylic-acid esters, process for their preparation and pharmaceutical compound containing them
US4176126A (en) Novel corticoids
US3956347A (en) Novel pregnanoic acid derivatives
US4102908A (en) Process for the preparation of pregnane derivatives
AP157A (en) Novel steroid derivatives.
US4456601A (en) 3-Chloro-pregnane derivatives and a process for the preparation thereof
HU184189B (en) Process for preparing pregnane derivatives substituted in position 17
US5200518A (en) Anti-inflammatory carboxycyclic acetal pregnane derivatives
US4011315A (en) 21-acetals and mixed acetals of steroidal 21-aldehydes, intermediates and methods of preparation
PL151627B1 (en) A method of new 16,17-acetylsubstituted pregna-21-new acid derivatives production
EP0994119B1 (en) Stereoselective process for the preparation of the 22R epimer of budesonide
US5215979A (en) 16,17-acetalsubstituted pregnane 21-oic acid derivatives
US3976637A (en) 3,20-Diketopregnenes having an 11β-acetal group
US4440689A (en) Acyloxysteroids and process for producing same
EP1207165A2 (en) Isomerisation of 6beta-fluorosteroids into the corresponding 6alpha-fluoro derivatives
KR820001643B1 (ko) 6-할로-프레그난류의 개량된 제조방법
HU195519B (en) Process for producing 11beta, 21-dihydroxy-16alpha,17-(butilidene-bis-oxy)-pregna-1,4-dien-3,20-dione of 22 r/s isomer ratio of approx, one to one
PL121467B1 (en) Process for preparing novel corticoids

Legal Events

Date Code Title Description
RH Patent void